Navigation Links
Robotic Surgery Oversold on Hospital Websites, Study Contends
Date:5/22/2011

tic longer and needing to have a second incision to place the robotic arm, he said.

In addition, the researchers looked at the claims made about the benefits of robotic surgery on these sites. "Frankly, the claims are overstated," Makary said. "Improved cancer outcomes -- that's ridiculous."

Thirty-two percent of the sites claimed that robotic surgery improved cancer outcomes, the researchers found. Makary pointed out that in the studies of robotic surgery, patients suffer as many complications as they do with conventional surgery.

Eighty percent of the robotic surgeries done in the United States are urological and gynecological, Makary said. There have been no randomized trials in these areas comparing robotic and conventional surgery, he said.

"To me, this is exactly what is wrong with American health care," Makary said. "We are adopting technology without being up front about the outcomes to consumers. And we adopt technology before we properly evaluate it."

The report is published in the May online edition of the Journal for Healthcare Quality.

For the study, Makary's team looked at the websites of 400 hospitals with 200 beds or more. They looked for whether robotic surgery was available and what information was provided on the hospital's website in June 2010.

They wanted to see how many hospitals used photos and text directly from the manufacturer of the device and what claims were made about the efficacy of robotic surgery.

The researchers found 41 percent of the websites detailed the availability of robotic surgery and how it worked. In addition, 37 percent of these sites had the information on the home page and 66 percent had a link to another page.

The information on 73 percent of these sites came directly from the manufacturer and 33 percent offered a direct link to the manufacturer's site, Makary's group found.

Moreover, 89 percent of these sites said that robotic surgery was better than
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Hospitals misleading patients about benefits of robotic surgery, study suggests
2. Mayo Clinic finds robotic surgery effective for removing hard-to-reach throat cancer
3. Researchers find anatomic differences after robotic-assisted radical prostatectomy
4. Robotic surgery put to the test for bowel cancer
5. CMUs Takeo Kanade wins ACM/AAAI Award for career contributions to computer vision, robotics
6. NYU Langone offers new imaging technique to advance robotic surgery for patients
7. Acquisition of robotic technology leads to increased rates of prostate cancer surgery
8. New UCSF robotic pharmacy aims to improve patient safety
9. Future surgeons may use robotic nurse, gesture recognition
10. Robotic surgery of tremendous benefit to patients, say JGH researchers
11. 10 years later: Robotic surgery for prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Robotic Surgery Oversold on Hospital Websites, Study Contends
(Date:7/14/2014)... July 14, 2014 The North America ... in North America with analysis and forecast of revenue. ... grow from around $273.1 million in 2013 to $490.1 ... 2013 to 2018. , Browse through the TOC of ... idea of the in-depth analysis provided. This also provides ...
(Date:7/14/2014)... Employers looking to lower their ... more benefit options must understand how purchasing benefits ... are the future of employee benefits. , Horizon ... BCBSNJ) is offering a free webinar, The Future ... Options, to demonstrate how HorizonSelect, its private online ...
(Date:7/14/2014)... Continuing a steady trend of growth in the ... of first-quarter success with Orange Regional Medical Center, Nexus ... by CEO and President Dr. Virginia Feldman – has ... members. Robert Poltenovage has joined the Nexus ... LPN and Angelica D’Amico have joined the Nexus Health ...
(Date:7/14/2014)... The European Lecithin Market report explains ... and projection of revenue. The Lecithin Market in Europe ... 2012 to $315.9 million by 2019, at a CAGR ... the TOC of the European Lecithin Market report, to ... also provides a glimpse of the segmentation in the ...
(Date:7/14/2014)... use of antibiotics is still prevalent among terminal patients ... despite little evidence that the medications improve symptoms or ... effects. , The use of antibiotics is so engrained ... discharged from hospitals directly to a hospice program leave ... one fourth of them don,t have a documented infection ...
Breaking Medicine News(10 mins):Health News:The North America Biostimulant Market is Expected to Reach $490.1 Million by 2018 - New Report by MicroMarket Monitor 2Health News:The North America Biostimulant Market is Expected to Reach $490.1 Million by 2018 - New Report by MicroMarket Monitor 3Health News:No Cost Employer Webinar to Demonstrate How Private Exchanges Can Lower Benefit Costs While Increasing Options for Employees 2Health News:Nexus Health Resources Continues Growth, Outstanding Health Care Coordination With Addition of Three New Team Members 2Health News:The Lecithin Market in Europe is Expected to Reach $315.9 Million by 2019 - New Report by MicroMarket Monitor 2Health News:The Lecithin Market in Europe is Expected to Reach $315.9 Million by 2019 - New Report by MicroMarket Monitor 3Health News:Antibiotic use prevalent in hospice patients despite limited evidence of its value 2
... , TAMPA, Fla. , Jan. ... the United States Preventative Task Force (USPTF), the Obesity Action ... add health insurance coverage of the recommended childhood obesity treatments. ... treating childhood obesity in moderate to intensive programs helps children ...
... , MORRISTOWN, N.J. , Jan. 19 ... a leading specialty pharmaceutical company, today confirmed that its subsidiary, ... (ANDA) with the U.S. Food and Drug Administration (FDA) seeking ... the expiration of U.S. Patent No. 5,827,529.  Watson,s lidocaine topical ...
... , Berk Prepares to Return as CEO , ... President Joel Seligman today announced that on March 1 ... full-time CEO of the Medical Center while Mark B. Taubman ... of Rochester School of Medicine and Dentistry .   , "I am excited ...
... will be held in Barcelona, Spain (Centre Convencions Internacional ... 24 - Saturday 27 March 2010. The ... the only one that involves all the major players ... between clinicians, scientists and patients in a partnership of ...
... survivors wait up to five years before disclosing they were ... Montral, the Universit du Qubec Montral and the Universit ... . "The number of victims who never reveal their ... very high," says co-author Mireille Cyr, a psychology professor of ...
... closely supported by a nurse-physician primary care team are twice ... those who receive usual care, according to a study by ... The research, published online in the latest edition of the ... 18 months of a randomized controlled trial, Guided Care recipients ...
Cached Medicine News:Health News:Obesity Action Coalition Calls on Insurers and Employers to Increase Access to Childhood Obesity Treatments Based on Recent United States Preventative Task Force Recommendations 2Health News:Watson Confirms Filing of FDA Application for Generic Lidoderm(R) 2Health News:Watson Confirms Filing of FDA Application for Generic Lidoderm(R) 3Health News:New Dean of School of Medicine and Dentistry Announced 2Health News:New Dean of School of Medicine and Dentistry Announced 3Health News:Disclosing sexual abuse is critical 2Health News:Guided Care participants rate quality of health care high 2
(Date:7/14/2014)... A new Manhattan Research study, ... finds that members of pharmacy and therapeutics ... and pharmacy benefits managers (PBMs) are shifting the ... of formulary decision makers report that they are ... decision making process today than a year ago. ...
(Date:7/14/2014)...  Clinicians at a leading cancer center in ... first in the country to commence advanced lung, ... Clinac® medical linear accelerator from Varian Medical Systems ... High Intensity Mode dose delivery capability, which is ... treatment times and deliver stereotactic body radiotherapy and ...
(Date:7/14/2014)... 14, 2014  Patients and patient advocates are rallying ... and other major pharmacy benefit managers (PBMs) begin unprecedented ... impact millions of patients who rely on compounded medicines ... pain from cancer, diabetes and other illnesses. Express Scripts ... on July 15. In a matter of ...
Breaking Medicine Technology:Digital Resources Play Critical Role in Formulary Decision Making 2Digital Resources Play Critical Role in Formulary Decision Making 3Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator 2Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator 3Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 2Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 3Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 4
... SOUTHAMPTON, England, June 29 Vantia ... drugs,targeting large, underserved medical markets, announces positive results ... development compound VA106483 for,nocturia. The trial showed that ... sustained anti-diuretic effect in patients, as determined by,increased ...
... England and TOKYO, June 29 , ... Sosei Group Corporation ("Sosei"; TSE Mothers ... commencement of a Phase III,clinical study by Novartis, with NVA237, ... obstructive pulmonary disease,(COPD). NVA237 is a dry powder formulation for ...
Cached Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4
Disposable Feather Blades, 50 per pack...
Knife sharpening back for Standard Knife, C Profile...
... The Cryostage freezing stage is a refrigerated design ... holder, primarily for use with the 8000 sledge ... sledge microtomes. ,The refrigerated stage gives a large ... surface is ridged to provide good adhesion between ...
... necessary to cool a specimen below room temperature. ... most microtomes and will permit specimen cooling from ... The equipment consists of a cooling stage and ... suited for operation with a base sledge microtome, ...
Medicine Products: